focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 133.00
High: 133.00
Low: 133.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tender Offer

28 Jun 2023 15:53

RNS Number : 2794E
Nationwide Building Society
28 June 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN (1) THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), (2) THE REPUBLIC OF ITALY, OR (3) ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Nationwide Building Society announces results of

its Open Market Repurchase Exercise

in respect of its Core Capital Deferred Shares

28 June 2023.  On 20 February 2023, Nationwide Building Society (Nationwide) announced the launch of an open market repurchase facility (the OMR Facility) under which it may, from time to time and in its sole discretion, seek to repurchase limited numbers of the Core Capital Deferred Shares of £1 nominal amount each (ISIN: GB00BBQ33664) (the CCDS) issued by Nationwide. On 26 June 2023, Nationwide announced the commencement of the second open market repurchase exercise under the OMR Facility (the OMR Exercise 2023-2).

The OMR Exercise 2023-2 was made on the terms and subject to the conditions contained in the announcement made by Nationwide on 26 June 2023 (the Launch Announcement). Capitalised terms used, but not defined, in this announcement have the meanings given to them in the Launch Announcement.

The OMR Tender Period expired at 3.00 p.m. (London time) on 28 June 2023, and Nationwide announces today the results of the OMR Exercise 2023-2.

Results of OMR Exercise 2023-2

Nationwide announces that it has decided to set the OMR Acceptance Amount at 657,547 CCDS, and that Nationwide will accordingly accept for purchase CCDS validly tendered pursuant to the OMR Exercise 2023-2 subject to application of a Scaling Factor of 55.34 per cent., as described in the Launch Announcement.

The expected settlement date for CCDS validly tendered during the OMR Tender Period and accepted for purchase by Nationwide is 3 July 2023 (the Settlement Date).

On the Settlement Date, each Eligible Holders of CCDS validly tendered for purchase pursuant to the OMR Exercise 2023-2 and accepted for purchase will receive an amount (rounded down to the nearest £0.01, with half a penny rounded upwards) equal to the sum of (i) the Purchase Price of £114.06 per CCDS accepted for purchase from such Eligible Holder and (ii) an Amount Attributable to Potential Future Distributions of £0.36407104 per CCDS accepted for purchase from such Eligible Holder.

Nationwide intends to hold all CCDS purchased by it pursuant to the OMR Exercise 2023-2 in treasury, and future re-sales of any purchased CCDS may occur from time to time at the sole discretion of Nationwide. The Conditions of the CCDS provide that any such re-sale will not be subject to pre-emption rights.

Summary

Description of the CCDS

ISIN

OMR Acceptance Amount

Scaling Factor

Aggregate number of CCDS outstanding following the OMR Exercise 2023-2

Nationwide's Core Capital Deferred Shares of £1 nominal amount each

GB00BBQ33664

657,547 CCDS

55.34 per cent.

9,122,345*

* This figure excludes the CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-2 or previously purchased by Nationwide and held in treasury, which (for so long as they are held by Nationwide in treasury) will be deemed not to be outstanding for certain purposes under the Conditions of the CCDS.

UBS AG London Branch (Telephone: +44 20 7568 1121; Attention: Liability Management Group; Email: ol-liabilitymanagement-eu@ubs.com) is acting as Dealer Manager in connection with the OMR Exercise 2023-2.

LEI of Nationwide Building Society: 549300XFX12G42QIKN82

DISCLAIMER

This announcement must be read together with the Launch Announcement. No offer or invitation to acquire any securities is being made pursuant to this announcement.

The distribution of this announcement and the Launch Announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Launch Announcement come(s) are required by Nationwide and the Dealer Manager to inform themselves about, and to observe, any such restrictions.

The OMR Exercise 2023-2 has now expired and no additional CCDS will be accepted for purchase pursuant to the OMR Exercise 2023-2.

This announcement is made by Nationwide, and the Dealer Manager does not accept any responsibility for the contents of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENKZGZVDRZGFZM
Date   Source Headline
17th Nov 20177:00 amRNSNationwide Building Society - Interim Results 2017
2nd Nov 20173:15 pmRNSOutcome of Audit Tender
16th Oct 20174:09 pmRNSPublication of Final Terms
14th Sep 20171:45 pmRNSDTR 5 Announcement
14th Sep 20178:41 amRNSAdmission to trading on the London Stock Exchange
12th Sep 20175:18 pmRNSStabilisation Notice
12th Sep 20177:00 amRNSPublication of a Prospectus
7th Sep 20172:02 pmRNSIssue of CCDS
7th Sep 20179:34 amRNSStabilisation Notice
6th Sep 20179:49 amRNSIssue of CCDS
31st Aug 20175:43 pmRNSPublication of a Prospectus
11th Aug 20176:31 pmRNSPublication of Suppl.Prospcts (Replacement)
11th Aug 20175:25 pmRNSPublication of Suppl.Prospcts
11th Aug 20177:00 amRNSInterim Management Statement
26th Jul 20179:50 amRNSRedemption of Callable Reset Subordinated Notes
24th Jul 201710:14 amRNSPublication of Final Terms
20th Jul 20173:23 pmRNSResult of AGM
18th Jul 20172:39 pmRNSStabilisation Notice - Nationwide
18th Jul 20172:36 pmRNSStabilisation Notice - Nationwide
18th Jul 20178:27 amRNSStabilisation Notice - Nationwide
30th Jun 20175:02 pmRNSPublication of a Prospectus
2nd Jun 20173:11 pmRNSPublication of Final Terms
2nd Jun 20173:10 pmRNSPublication of Final Terms
2nd Jun 20173:07 pmRNSPublication of Final Terms
24th May 20176:13 pmRNSPublication of Suppl.Prospcts
23rd May 20177:00 amRNSPreliminary Results Announcement
18th May 20178:00 amRNSDoc re. Appointment of Non-Executive Director
3rd May 201712:01 pmRNSCCDS - Notification of Adjustment to PIR Cap
13th Apr 20173:46 pmRNSPublication of Final Terms
10th Apr 20178:48 amRNSStabilisation Notice - NWIDE 6YR EUR
3rd Apr 20172:41 pmRNSNotice of Updated Swap Agreements
21st Mar 201712:35 pmRNSPublication of Final Terms
23rd Feb 20172:49 pmRNSPublication of Final Terms
10th Feb 20171:14 pmRNSPublication of Interim Management Statement (Q3)
10th Feb 20177:00 amRNSInterim Management Statement
8th Feb 201710:04 amRNSPublication of Final Terms
23rd Jan 20171:41 pmRNSNotice of Amendments to Transaction Documents
18th Jan 201710:38 amRNSDoc re. Appointment of Non-Executive Director
19th Dec 20161:29 pmRNSNotice of Cancellation of Listing - PIBS
30th Nov 20167:15 amRNSNationwide's Response to the Stress Test Results
18th Nov 201612:41 pmRNSSupplement and Interim Results
18th Nov 20167:00 amRNSHalf-year Report
17th Oct 201612:30 pmRNSNotice by Issuer to the PIBS holders - Redemption
12th Sep 20164:03 pmRNSPublication of Final Terms
31st Aug 20166:00 pmRNSPublication of a Prospectus
12th Aug 20163:15 pmRNSPublication of Supplementary Prospectus
12th Aug 20167:00 amRNSInterim Management Statement
3rd Aug 20164:03 pmRNSPublication of a Prospectus
26th Jul 20164:58 pmRNSPublication of Final Terms
25th Jul 20163:39 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.